Aekyung Chemical애경케미칼
161000 · KOSPI · ₩161000 · 애경케미칼
₩10,460▲ ₩450 (4.50%)End-of-day · Oct 27, 2026 · End-of-day prices.
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | ₩1.5T | ₩1.6T | ₩1.8T | ₩2.2T | ₩1.6T |
| Cost of sales | ₩1.3T | ₩1.5T | ₩1.6T | ₩2T | ₩1.4T |
| Gross profit | ₩119B | ₩141B | ₩176B | ₩222B | ₩158B |
| Operating income | −₩10B | ₩15B | ₩45B | ₩95B | ₩93B |
| Net income | −₩4.9B | ₩8.5B | ₩33B | ₩59B | ₩77B |
| Net income to shareholders | −₩2.9B | ₩4B | ₩33B | ₩60B | ₩77B |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Total assets | ₩1.4T | ₩1.4T | ₩1.3T | ₩1.2T | ₩1.2T |
| Current assets | ₩500B | ₩512B | ₩587B | ₩592B | ₩605B |
| Cash and equivalents | ₩69B | ₩67B | ₩91B | ₩99B | ₩63B |
| Total liabilities | ₩678B | ₩615B | ₩572B | ₩506B | ₩556B |
| Current liabilities | ₩482B | ₩443B | ₩480B | ₩474B | ₩482B |
| Borrowings | ₩499B | ₩389B | ₩331B | ₩242B | ₩259B |
| Total equity | ₩716B | ₩741B | ₩736B | ₩728B | ₩689B |
| Shareholders' equity | ₩714B | ₩737B | ₩736B | ₩728B | ₩693B |
Cash flow
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash from operations | ₩28B | ₩47B | ₩80B | ₩137B | −₩20B |
| Capital spending | ₩98B | ₩120B | ₩80B | ₩55B | ₩37B |
| Free cash flow | −₩70B | −₩74B | −₩531M | ₩82B | −₩56B |
| Dividends paid | ₩14B | ₩12B | ₩26B | ₩26B | ₩11B |
Consolidated where available. Amounts in won.
Also known as: Aekyung Chemical / 애경케미칼 / 161000 / KRX:161000
Source: KRX statistical information